CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-19 | ROBERTS BRIAN KENNETH Chief Medical Officer | Grant or award | +123,000 | 280,352 | ||
| 2025-11-19 | ROBERTS BRIAN KENNETH Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2025-11-19 | Karnawat Sunil Ratilal Chief Commercial Officer | Grant or award | +32,000 | 59,442 | ||
| 2025-11-19 | Karnawat Sunil Ratilal Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-11-19 | Elam Nevan C CEO | Grant or award | +317,000 | 609,119 | ||
| 2025-11-19 | Elam Nevan C CEO | Grant or award · Employee Stock Option (Right to Buy) | +186,000 | 186,000 | ||
| 2025-11-19 | Evans Daron CFO | Grant or award | +107,000 | 375,900 | ||
| 2025-11-19 | Evans Daron CFO | Grant or award · Employee Stock Option (Right to Buy) | +63,000 | 63,000 | ||
| 2025-11-19 | KREHER NERISSA Director | Grant or award | +21,000 | 58,576 | ||
| 2025-11-19 | KREHER NERISSA Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2025-11-19 | Hogenhuis Wladimir Director | Grant or award | +21,000 | 114,025 | ||
| 2025-11-19 | Hogenhuis Wladimir Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2025-11-19 | Harris Erik Director | Grant or award | +21,000 | 21,000 | ||
| 2025-11-19 | Harris Erik Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2025-11-19 | Kim Young-Jin Director | Grant or award | +21,000 | 170,950 | ||
| 2025-11-19 | Kim Young-Jin Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2025-11-19 | FAUCHET PHILIPPE Director | Grant or award | +21,000 | 55,500 | ||
| 2025-11-19 | FAUCHET PHILIPPE Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2025-11-19 | Labrucherie Gil M Director | Grant or award | +21,000 | 55,500 | ||
| 2025-11-19 | Labrucherie Gil M Director | Grant or award · Director Stock Option (Right to Buy) | +12,000 | 12,000 |
Page 2 of 14 · 279 trades